Podcast Episodes
Back to Search
Courts, Cannabis, and Compliance: WNBA Policy Shifts vs. Impending Hemp Regulations
The sports industry is witnessing a landmark normalization of cannabis, highlighted by the WNBA’s recent collective bargaining agreement which remove…
2 months, 1 week ago
DOJ Rescheduling Preview | Virginia Amending Adult Use | Illinois Introduces Hemp Ban?
We report on a wave of highly targeted legislative, legal, and medical updates aimed at curbing market disorder and protecting public health.
In the U…
2 months, 2 weeks ago
Clarifying Cannabis From THCA Loopholes to Schedule III Shifts
Dr. Priyanka Sharma, co-CEO of Kazmira Therapeutics and fellow co-CEO Pulak Sharma, cut through the confusion surrounding the rapidly evolving cannab…
2 months, 3 weeks ago
Kazmira Therapeutics and the Future of CBD Medicine
Kazmira Therapeutics is revolutionizing the CBD landscape by transitioning cannabinoids from over-the-counter health supplements to precision, pharma…
2 months, 4 weeks ago
The Hemp Lifeline: States Open Cannabis Gateways as Federal Lawsuit Targets MSOs
As a massive federal hammer prepares to fall on the hemp industry, progressive states are throwing operators a regulatory lifeline—just as the legal …
3 months ago
Federal Rescheduling and the BUILD Act: Capitol Hill’s Shift on Cannabis Reform
Blunt Business zeroes in on major developments unfolding on the congressional front. It highlights how impending federal rescheduling could significa…
3 months, 1 week ago
Georgia Expands Medical Access and D.C. Beats Cannabis Lawsuit
This week on Blunt Business, we’re diving into two massive legal shifts reshaping cannabis markets on opposite sides of the country. First, we break …
3 months, 2 weeks ago
$15 Billion Refund? Navigating Retroactive 280E Relief
As the federal government moves toward rescheduling marijuana, the cannabis industry is eyeing a massive financial shift: the potential for $15 billi…
3 months, 3 weeks ago
Can Las Vegas Cash In on the Cannabis Reclassification?
The potential move to Schedule III presents a massive financial opportunity for "Sin City," yet current local friction threatens to stall that moment…
4 months ago
A Psychedelic and Cannabis Research Revolution On the Horizon?
This episode of Blunt Business explores a significant shift in federal drug policy following a new executive order aimed at accelerating research int…
4 months, 2 weeks ago